Allocations
Law firm Howard Kennedy has advised AIM listed Fitbug Holdings on its latest fund raising that has seen the company raise a further GBP1,665,000, and on the restructuring of its existing loans.
The fund raising comprises:
• GBP665,000 raised by way of a new share placing;
• GBP350,000 raised by subscription from NW1 Investments; and
• A new GBP650,000 convertible loan in favour of NW1 Investments.
At the same time Fitbug has agreed the restructuring of its loans, which extend the terms until 2017 and reduces the interest payable.
The Howard Kennedy team was led by Partner and Head of
Aurelius Group increased its total consolidated revenues in the first half of 2015 by 16 per cent to EUR932.7 million (first half of 2014: EUR804.0 million).
On an annual basis, consolidated revenues reached EUR2,085.5 million – an increase of 28 per cent – and thus exceeded EUR2 billion for the first time.
The Group’s positive performance in the first half of 2015 was reflected in a 22 per cent increase in operating EBITDA to
Investment banking boutique Zeus Capital has advised clinical stage biopharmaceutical group Motif Bio on its GBP22m fundraise.
Based in London, Motif Bio has responded directly to the threat posed by antibiotic-resistant bacteria. The firm's lead product, iclaprim, is currently in clinical development. The drug is set to fill a major market void, as it is designed to fight serious and life-threatening hospital infections, responsible for at least 23,000 deaths in the US in 2013.
The firm had announced its intention to fundraise last month, but the deal was conditional upon securing a key designation by drug regulators in the
Premier, Inc has acquired Healthcare Insights, LLC for USD65 million in cash. Healthcare Insights is a privately-held, integrated financial management software developer that provides hospitals and healthcare systems with budgeting, forecasting, labor productivity and cost analytic capabilities.
"As the healthcare industry becomes more complex, value-driven, and data-dependent, the need for health systems to clearly understand their performance in every arena is a top concern," says Keith J Figlioli, Premier's senior vice president of health informatics. "It is not enough to have financial, operational and clinical data. Health systems must understand how to translate that information into effective cost containment strategies,
Lincoln Park Capital Fund has signed a stock purchase agreement with GelTech Solutions for up to USD10 million of common stock.
“With our recent sales increases with several state agencies in the Wildland Division and our continued penetration in the Utilities Division, this is a great time to enter into this funding arrangement with Lincoln Park, an institutional investor that has partnered with GelTech in the past to supplement the Company’s capital needs," says Michael Reger, GelTech’s president. "The funds will provide the Company with capital, if needed, to fund operations, including supporting working capital needs, increasing inventory and investing
Questback, Europe’s leading supplier of solutions for Enterprise Feedback, Social CRM and online surveys, is raising GBP12 million in new capital from existing investors.
The transaction will strengthen the equity base by approximately GBP12m (NOK150 million). The largest investors are Reiten & Co Capital Partners VII L.P. and First Fellow Oy. Other existing investors are also offered to participate.
“We see the business of Questback as a great investment case, and we decided to increase our investment to support the company in its next growth phase,” says Terje Bakken, partner at Reiten & Co and chairman of the board
Private equity firm Flexpoint Ford has held the first and final closing of its third private equity fund, Flexpoint Fund III at USD950 million, along with a new investment vehicle, Flexpoint Special Assets Fund at USD317 million.
The initial targets for the funds were USD750 million and USD250 million, respectively.
Fund III plans to invest in minority and majority equity stakes in financial services and healthcare companies, utilising Flexpoint Ford's demonstrated proprietary sourcing and operating capabilities. The Special Assets Fund will further leverage Flexpoint Ford's existing financial services expertise by investing in financial assets such as loans, leases, books
VATBox, a cloud-based provider of automated VAT recovery and governance solutions, has closed a USD24 million financing round led by Viola Private Equity with participation of existing private investors.
The funding will further fuel VATBox's aggressive growth plans, accelerating its expansion in the massive, growing market of VAT recovery and governance.
VATBox was founded in 2013 by CEO Isaac Saft and President Noam Guzman. Leveraging their extensive experience in the enterprise software market, together with Comverse former SVP of Global Operations Yoram Hordan (COO) and a team of 60 employees, VATBox has become a significant player in the field
The average time taken for private real estate funds to reach a final close so far this year is the longest it has ever been. This extract from Preqin Real Estate Spotlight: August 2015 explores the key trends that emerge when comparing time on the road to fundraising success and past performance in an increasingly competitive market.
The real estate fundraising landscape remains a competitive one, despite increasing institutional demand for exposure to the asset class. Preqin’s Real Estate Online contains detailed profiles for over 4,900 private real estate funds worldwide, which include information on strategy and geographic preferences, fundraising,
PHEMI has raised a USD12.2 million round of venture financing to expand the commercialisation phase of the company.
Secured by a combination of new and existing investors, the financing was co-led by CTI Life Sciences Fund (CTI) and British Columbia Discovery Fund (Discovery Capital). It also included significant participation from early investors BDC Capital Healthcare Venture Fund and Yaletown Venture Partners.
A team of serial entrepreneurs, Dr Paul Terry, Adam Lorant and John Seminerio – with expertise in developing and commercialising innovative business and technology solutions for a wide variety of industries, including healthcare, telecommunications and high-performance computing –
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
